Neonatal candidiasis
ICD-10 P37.5 is a billable code used to indicate a diagnosis of neonatal candidiasis.
Neonatal candidiasis is a fungal infection caused by Candida species, primarily Candida albicans, that can occur in newborns, particularly those who are premature or have low birth weight. This condition is characterized by the presence of white patches in the oral cavity (thrush), diaper rash, and in severe cases, systemic infection. The risk factors include maternal diabetes, prolonged antibiotic use during labor, and immunosuppression. Diagnosis is typically made through clinical examination and, if necessary, culture of the organism. Treatment often involves antifungal medications, such as nystatin or fluconazole, and supportive care. Early recognition and management are crucial to prevent complications, including systemic candidiasis, which can lead to significant morbidity in neonates. The condition is part of a broader category of congenital infections that may also include congenital tuberculosis and toxoplasmosis, which can have overlapping clinical presentations and require careful differential diagnosis.
Detailed clinical notes on the infant's condition, treatment plan, and response to therapy.
Neonates in the NICU presenting with oral thrush or diaper rash due to candidiasis.
Consideration of the infant's gestational age and birth weight when assessing risk.
Comprehensive history and physical examination notes, including maternal health factors.
Pediatric follow-up visits for infants previously diagnosed with candidiasis.
Monitoring for potential long-term effects of candidiasis on growth and development.
Used when a neonate with candidiasis requires critical care management.
Detailed notes on the clinical status and interventions provided.
Neonatologists should document the rationale for critical care services.
Common symptoms include white patches in the mouth (oral thrush), diaper rash, and in severe cases, signs of systemic infection such as fever and irritability.
